ALB and cancer: Another solution to presented problem may be adding albumin to the treatment regimen, as it appears to be able to increase the binding of drug to albumin, therefore to increase half-life of circulating drug and its entry into cancer cells, making it useful way to modify treatment (Bagheri and Saboury, 2021).